Mark R. Geier - Miscellaneous

Doctor Data - Generic Profile Picture

Copyright 2012 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Advertisement

Posted: 01/11/2012

Mark R. Geier - Miscellaneous          

ACTIONS TAKEN:

 

Cease and Desist Order 1/25/2011

Suspension Affirmed 5/12/2011

Summary Suspension 4/27/2011

BOARD AWARE OF ISSUE:

Complaint 8/15/2006   

QUOTES FROM DISCIPLINARY ACTION DOCUMENTS:

--“The Board determined that the physician’s conduct constituted a substantial likelihood of a risk of serious harm to the public health, safety and welfare based on the physician’s experimental treatment of autistic children with Lupron.”

--“With regard to administering Lupron to autistic children, the Respondent has been quoted as saying ‘If you want to call it a nasty name, call it chemical castration.  If you want to call it something nice, say you are lowering testosterone’.”

--“The complainant alleged the Respondent promotes the use of Lupron as a treatment for autism in children.  The complainant alleged that the Respondent…practices outside the scope of his expertise and the prevailing standard care for autism…experimented on children without a rational scientific theory or the supervision of a qualified review board.”

--“The Respondent endangers autistic children and exploits their parents by administering to the children a treatment protocol that has a known substantial risk of serious harm and which is neither consistent with evidence-based medicine nor generally accepted in the relevant scientific community.”

TIME LAG ON ACTION:

4 YEARS, 8 MONTHS

Copyright 2012 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

  • Comments

 

 

Advertisement

 

Bad Medicine Explained


  1. BAD MEDICINE | How this works

    BAD MEDICINE | How this works

    ABC2 Investigator Joce Sterman has reviewed thousands of pages of documents for her Bad Medicine report.
    INSIDE | Tools, information